BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 23318437)

  • 1. Knockdown of RNF2 induces apoptosis by regulating MDM2 and p53 stability.
    Wen W; Peng C; Kim MO; Ho Jeong C; Zhu F; Yao K; Zykova T; Ma W; Carper A; Langfald A; Bode AM; Dong Z
    Oncogene; 2014 Jan; 33(4):421-8. PubMed ID: 23318437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNF2/Ring1b negatively regulates p53 expression in selective cancer cell types to promote tumor development.
    Su WJ; Fang JS; Cheng F; Liu C; Zhou F; Zhang J
    Proc Natl Acad Sci U S A; 2013 Jan; 110(5):1720-5. PubMed ID: 23319651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromatin modifiers Mdm2 and RNF2 prevent RNA:DNA hybrids that impair DNA replication.
    Klusmann I; Wohlberedt K; Magerhans A; Teloni F; Korbel JO; Altmeyer M; Dobbelstein M
    Proc Natl Acad Sci U S A; 2018 Nov; 115(48):E11311-E11320. PubMed ID: 30413623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of RNF2 induces cell cycle arrest and apoptosis in prostate cancer cells through the upregulation of TXNIP.
    Wei M; Jiao D; Han D; Wu J; Wei F; Zheng G; Guo Z; Xi W; Yang F; Xie P; Zhang L; Yang AG; Wang H; Qin W; Wen W
    Oncotarget; 2017 Jan; 8(3):5323-5338. PubMed ID: 28029659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MDM2 Associates with Polycomb Repressor Complex 2 and Enhances Stemness-Promoting Chromatin Modifications Independent of p53.
    Wienken M; Dickmanns A; Nemajerova A; Kramer D; Najafova Z; Weiss M; Karpiuk O; Kassem M; Zhang Y; Lozano G; Johnsen SA; Moll UM; Zhang X; Dobbelstein M
    Mol Cell; 2016 Jan; 61(1):68-83. PubMed ID: 26748827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypomethylation-Linked Activation of PLCE1 Impedes Autophagy and Promotes Tumorigenesis through MDM2-Mediated Ubiquitination and Destabilization of p53.
    Chen Y; Xin H; Peng H; Shi Q; Li M; Yu J; Tian Y; Han X; Chen X; Zheng Y; Li J; Yang Z; Yang L; Hu J; Huang X; Liu Z; Huang X; Zhou H; Cui X; Li F
    Cancer Res; 2020 Jun; 80(11):2175-2189. PubMed ID: 32066565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ring finger protein 2 promotes colorectal cancer progression by suppressing early growth response 1.
    Wei F; Jing H; Wei M; Liu L; Wu J; Wang M; Han D; Yang F; Yang B; Jiao D; Zheng G; Zhang L; Xi W; Guo Z; Yang AG; Qin W; Zhou Y; Wen W
    Aging (Albany NY); 2020 Dec; 12(24):26199-26220. PubMed ID: 33346749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ribosomal L1 domain-containing protein 1 coordinates with HDM2 to negatively regulate p53 in human colorectal Cancer cells.
    Ding L; Zhang Z; Zhao C; Chen L; Chen Z; Zhang J; Liu Y; Nie Y; He Y; Liao K; Zhang X
    J Exp Clin Cancer Res; 2021 Aug; 40(1):245. PubMed ID: 34362424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNF2 promotes the progression of colon cancer by regulating ubiquitination and degradation of IRF4.
    Wang J; Ouyang X; Zhou Z; Mao S; Niu X; Li H; Xu W; Song Y; Cao J; Lai B
    Biochim Biophys Acta Mol Cell Res; 2022 Jan; 1869(1):119162. PubMed ID: 34670117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRIAD1 inhibits MDM2-mediated p53 ubiquitination and degradation.
    Bae S; Jung JH; Kim K; An IS; Kim SY; Lee JH; Park IC; Jin YW; Lee SJ; An S
    FEBS Lett; 2012 Sep; 586(19):3057-63. PubMed ID: 22819825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heat shock protein gp96 decreases p53 stability by regulating Mdm2 E3 ligase activity in liver cancer.
    Wu B; Chu X; Feng C; Hou J; Fan H; Liu N; Li C; Kong X; Ye X; Meng S
    Cancer Lett; 2015 Apr; 359(2):325-34. PubMed ID: 25637791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of RNF2 knockdown on apoptosis and radiosensitivity in glioma U87 cells].
    Zhou C; Yang F; Xi W; Wei M; Zheng G; Wang W; Yang A; Zhang J; Wen W
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 May; 30(5):471-5. PubMed ID: 24796740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapamycin increases the p53/MDM2 protein ratio and p53-dependent apoptosis by translational inhibition of mdm2 in cancer cells.
    Kao CL; Hsu HS; Chen HW; Cheng TH
    Cancer Lett; 2009 Dec; 286(2):250-9. PubMed ID: 19560264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetylation-dependent regulation of MDM2 E3 ligase activity dictates its oncogenic function.
    Nihira NT; Ogura K; Shimizu K; North BJ; Zhang J; Gao D; Inuzuka H; Wei W
    Sci Signal; 2017 Feb; 10(466):. PubMed ID: 28196907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the MDM2-P53 pathway and tumor growth by PICT1 via nucleolar RPL11.
    Sasaki M; Kawahara K; Nishio M; Mimori K; Kogo R; Hamada K; Itoh B; Wang J; Komatsu Y; Yang YR; Hikasa H; Horie Y; Yamashita T; Kamijo T; Zhang Y; Zhu Y; Prives C; Nakano T; Mak TW; Sasaki T; Maehama T; Mori M; Suzuki A
    Nat Med; 2011 Jul; 17(8):944-51. PubMed ID: 21804542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiosensitization of esophageal carcinoma cells by knockdown of RNF2 expression.
    Yang XX; Ma M; Sang MX; Wang XX; Song H; Liu ZK; Zhu SC
    Int J Oncol; 2016 May; 48(5):1985-96. PubMed ID: 26936624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enigma negatively regulates p53 through MDM2 and promotes tumor cell survival in mice.
    Jung CR; Lim JH; Choi Y; Kim DG; Kang KJ; Noh SM; Im DS
    J Clin Invest; 2010 Dec; 120(12):4493-506. PubMed ID: 21060154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct effects of Bmi1 on p53 protein stability inactivates oncoprotein stress responses in embryonal cancer precursor cells at tumor initiation.
    Calao M; Sekyere EO; Cui HJ; Cheung BB; Thomas WD; Keating J; Chen JB; Raif A; Jankowski K; Davies NP; Bekkum MV; Chen B; Tan O; Ellis T; Norris MD; Haber M; Kim ES; Shohet JM; Trahair TN; Liu T; Wainwright BJ; Ding HF; Marshall GM
    Oncogene; 2013 Aug; 32(31):3616-26. PubMed ID: 22907436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. USP7 Enforces Heterochromatinization of p53 Target Promoters by Protecting SUV39H1 from MDM2-Mediated Degradation.
    Mungamuri SK; Qiao RF; Yao S; Manfredi JJ; Gu W; Aaronson SA
    Cell Rep; 2016 Mar; 14(11):2528-37. PubMed ID: 26971997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of MDM2 inhibitor MI-219 against lung cancer cells alone or in combination with MDM2 knockdown, a XIAP inhibitor or etoposide.
    Zheng M; Yang J; Xu X; Sebolt JT; Wang S; Sun Y
    Anticancer Res; 2010 Sep; 30(9):3321-31. PubMed ID: 20944104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.